Benefit of tamoxifen in estrogen receptor positive DCIS of the breast

Lignende værker

• Survival Benefit of Tamoxifen in Estrogen Receptor-Negative and Progesterone Receptor-Positive Low Grade Breast Cancer Patients
  af: Yang, Li-Heng, et al.
  Udgivet: (2012)
• Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer
  af: Kim, Chungyeul, et al.
  Udgivet: (2011)
• Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
  af: Nordenskjöld, Anna, et al.
  Udgivet: (2016)
• Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells
  af: Gao, Pin, et al.
  Udgivet: (2018)
• Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer
  af: Fohlin, Helena, et al.
  Udgivet: (2020)